Orion Capital Management’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-20
Closed -$119 484
2024
Q1
$119 Hold
20
﹤0.01% 504
2023
Q4
$176 Hold
20
﹤0.01% 510
2023
Q3
$174 Buy
+20
New +$367 ﹤0.01% 500
2023
Q2
Sell
-20
Closed -$1.05K 346
2023
Q1
$1.05K Buy
+20
New +$704 ﹤0.01% 441

Other funds holding PALI

Orion Capital Management's PALI Position: Q2 2024 in Review

Orion Capital Management sold out of Palisade Bio (PALI) in Q2 2024, closing a stake of 20 shares — an estimated $119 sold.

Orion Capital Management first reported a position in PALI in Q1 2023 and held it in 4 quarters. The position peaked at $1.05K in Q1 2023. 8 funds tracked by Wall St. Rank hold PALI as of Q2 2024.

  • Orion Capital Management reported no remaining Palisade Bio position as of Q2 2024 after selling out during the quarter.
  • Orion Capital Management sold 20 Palisade Bio shares in Q2 2024, an estimated $119.
  • Orion Capital Management first reported a position in Palisade Bio in Q1 2023 and held it in 4 quarters.
  • Orion Capital Management's Palisade Bio position peaked at $1.05K in Q1 2023.
  • 8 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2024.

Based on Orion Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.